Drug Type Biological products |
Synonyms CRES102 |
Target |
Mechanism MBP stimulants(Myelin basic protein stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | NO | 16 Oct 2022 |